News | November 07, 2011

SNM Launches Web Site for Nuclear Medicine and Molecular Imaging Patients

November 7, 2011 – The Society of Nuclear Medicine (SNM) launched a new patient-focused website, discoverMI.org, to provide patients with information about nuclear medicine and molecular imaging and how it can play a critical role in the detection, treatment and management of diseases.

“Many times patients referred for a nuclear medicine or molecular imaging studies are nervous about what to expect,” said George Segall, M.D., SNM president. “By providing information and explaining the benefits of the study in an easy-to-understand format, we can offer them both help and support.”

The website focuses on three common disease areas: heart disease, cancer and brain disease. For each area, specific types of disease are detailed along with the various nuclear and molecular imaging procedures that are associated with each. General information on molecular imaging, an extensive glossary and a video library are also included on the site. Additionally, patients can stay up to date on the latest in molecular imaging news through Facebook and Twitter pages designed to complement the site.

DiscoverMI.org is supported by several patient advocacy groups that are a part of SNM’s Patient Advocacy Advisory Board (PAAB), including the Alzheimer’s Association, the American Thyroid Association, the Leukemia and Lymphoma Society, the Ovarian Cancer Alliance of Arizona, the Ovarian Cancer National Alliance, the American Heart Association, the Men’s Health Network and the Thyroid Cancer Survivors’ Association.

“I am thrilled that this comprehensive resource for patients is now available,” said Betsy de Parry, a member of SNM’s PAAB and author of Adventures in Cancer Land. Laurel Pracht, SNM PAAB member and patient advocate for the Ovarian Cancer National Alliance, added, “As a patient, it is critical to have access to user-friendly information about what is available for someone with your disease. The website provides information about both what is currently available in molecular imaging and how it may affect you.”

More than 16 million Americans undergo nuclear and molecular imaging and therapy procedures each year for a variety of conditions, including cancer, cardiovascular disease, neurological conditions and other physiological problems. Nuclear and molecular imaging procedures are an invaluable way to gather medical information that would otherwise be unavailable, require surgery or necessitate more expensive diagnostic tests.

For more information: www.snm.org

 

Related Content

PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
Overlay Init